GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bio Preventive Medicine Corp (ROCO:6810) » Definitions » Equity-to-Asset

Bio Preventive Medicine (ROCO:6810) Equity-to-Asset : 0.53 (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Bio Preventive Medicine Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Bio Preventive Medicine's Total Stockholders Equity for the quarter that ended in Dec. 2023 was NT$139.93 Mil. Bio Preventive Medicine's Total Assets for the quarter that ended in Dec. 2023 was NT$264.66 Mil. Therefore, Bio Preventive Medicine's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was 0.53.

The historical rank and industry rank for Bio Preventive Medicine's Equity-to-Asset or its related term are showing as below:

ROCO:6810' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.52   Med: 0.89   Max: 0.95
Current: 0.53

During the past 6 years, the highest Equity to Asset Ratio of Bio Preventive Medicine was 0.95. The lowest was 0.52. And the median was 0.89.

ROCO:6810's Equity-to-Asset is ranked worse than
62.2% of 1561 companies
in the Biotechnology industry
Industry Median: 0.67 vs ROCO:6810: 0.53

Bio Preventive Medicine Equity-to-Asset Historical Data

The historical data trend for Bio Preventive Medicine's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bio Preventive Medicine Equity-to-Asset Chart

Bio Preventive Medicine Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial 0.88 0.91 0.90 0.52 0.53

Bio Preventive Medicine Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.90 0.95 0.52 0.59 0.53

Competitive Comparison of Bio Preventive Medicine's Equity-to-Asset

For the Biotechnology subindustry, Bio Preventive Medicine's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bio Preventive Medicine's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bio Preventive Medicine's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Bio Preventive Medicine's Equity-to-Asset falls into.



Bio Preventive Medicine Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Bio Preventive Medicine's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=139.928/264.657
=0.53

Bio Preventive Medicine's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )=Total Stockholders Equity/Total Assets
=139.928/264.657
=0.53

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bio Preventive Medicine  (ROCO:6810) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Bio Preventive Medicine Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Bio Preventive Medicine's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Bio Preventive Medicine (ROCO:6810) Business Description

Traded in Other Exchanges
N/A
Address
No.18, Taiyuan Street, 1 of 6th Floor, Hsinchu County, Zhubei, TWN, 30265
Bio Preventive Medicine Corp is an innovative clinical-staged biotech company, focusing on early detection and prevention of diseases specialty of those high value added molecular diagnostic product.

Bio Preventive Medicine (ROCO:6810) Headlines

No Headlines